iOnctura's Seed VC Round

iOnctura raised a round of funding on June 21, 2017. Investors include Merck Ventures.

iOnctura, based in Geneva, Switzerland, is an immuno-oncology spin-out, formed around two assets from the Healthcare R&D portfolio of Merck, and three assets from Cancer Research Technology (CRT). iOn…

Articles about iOnctura's Seed VC Round: